Comorbidity | n (%) | Aboriginal aHR (95% CI)a | weight | n (%) | non-Aboriginal aHR (95% CI) a | weight |
---|---|---|---|---|---|---|
Alcohol abuse | 77 (9.9) | 1.73 (1.25–2.39) | 2 | 13 (1.7) | 1.07 (0.44–2.64) | 1 |
AMI | 32 (4.1) | 1.24 (0.75–2.04) | 1 | 8 (1.0) | 0.68 (0.21–2.18) | 0 |
Angina | 38 (4.9) | 1.21 (0.78–1.89) | 1 | 13 (1.7) | 2.48 (1.06–5.82) | 2 |
Anxiety and behavioural disorders | 14 (1.8) | 1.08 (0.44–2.66) | 1 | 8 (1.0) | 1.46 (0.35–6.01) | 1 |
Blood loss anaemia | 11 (1.4) | 1.42 (0.52–3.88) | 1 | ** | ** | ** |
Bowel disease | 18 (2.3) | 1.10 (0.54–2.25) | 1 | 5 (0.6) | 11.17 (3.73–33.5) | 11 |
Cardiac arrhythmias | 30 (3.9) | 0.80 (0.46–1.41) | 0 | 22 (2.8) | 0.99 (0.46–2.14) | 0 |
CHF | 36 (4.6) | 1.48 (0.96–2.28) | 1 | 14 (1.8) | 2.09 (1.00–4.37) | 2 |
Chronic viral hepatitis | 18 (2.3) | 0.97 (0.45–2.10) | 0 | ** | ** | ** |
Coagulopathy | 18 (2.3) | 1.06 (0.46–2.41) | 1 | 9 (1.2) | 1.36 (0.42–4.49) | 1 |
COPD | 83 (10.7) | 1.13 (0.81–1.59) | 1 | 34 (4.4) | 1.64 (0.92–2.90) | 2 |
CVD | 26 (3.4) | 1.33 (0.74–2.40) | 1 | 15 (1.9) | 2.12 (1.07–4.13) | 2 |
Deficiency anaemia | 22 (2.8) | 1.07 (0.56–2.01) | 1 | 14 (1.8) | 0.81 (0.29–2.27) | 0 |
Dementia | 6 (0.8) | 0.67 (0.16–2.72) | 0 | ** | ** | ** |
Depression | 20 (2.6) | 1.00 (0.49–2.04) | 1 | 9 (1.2) | 1.14 (0.28–4.64) | 1 |
Diabetes complicated | 58 (7.5) | 1.13 (0.76–1.68) | 1 | 6 (0.8) | 1.27 (0.17–9.31) | 1 |
Diabetes without complications | 84 (10.8) | 1.01 (0.72–1.42) | 1 | 21 (2.7) | 2.67 (1.39–5.13) | 3 |
Drug abuse | 29 (3.7) | 0.97 (0.54–1.75) | 0 | 6 (0.8) | 2.34 (0.73–7.52) | 2 |
Epilepsy | 13 (1.7) | 1.26 (0.55–2.88) | 1 | 6 (0.8) | 4.11 (1.27–13.3) | 4 |
Eye problems | 16 (2.1) | 1.50 (0.83–2.70) | 1 | ** | ** | ** |
Fluid and electrolyte disorders | 18 (2.3) | 1.43 (0.75–2.71) | 1 | 9 (1.2) | 3.22 (1.40–7.38) | 3 |
Hypertension uncomplicated | 105 (13.5) | 1.01 (0.74–1.38) | 1 | 55 (7.1) | 1.07 (0.63–1.80) | 1 |
Hypothyroidism | 12 (1.5) | 1.77 (0.78–4.04) | 2 | ** | ** | ** |
Intestinal disorders | 14 (1.8) | 0.86 (0.35–2.12) | 0 | 15 (1.9) | 0.58 (0.18–1.85) | 0 |
Joint and spinal disorders | 5 (0.6) | 2.62 (0.64–10.8) | 3 | ** | ** | ** |
Metabolic disorders | 48 (6.2) | 1.31 (0.88–1.95) | 1 | 13 (1.7) | 0.87 (0.32–2.36) | 0 |
Mild liver disease | 24 (3.1) | 2.00 (1.17–3.40) | 2 | ** | ** | ** |
Moderate/Severe liver disease | ** | ** | ** | 6 (0.8) | 3.23 (1.29–8.05) | 3 |
Obesity | 17 (2.2) | 0.61 (0.22–1.64) | 0 | ** | ** | ** |
Osteoporosis | 6 (0.8) | 0.82 (0.26–2.59) | 0 | ** | ** | ** |
Other cardiac conditions | 58 (7.5) | 1.34 (0.92–1.95) | 1 | 14 (1.8) | 2.97 (1.35–6.56) | 3 |
Other neurological disorders | 11 (1.4) | 0.90 (0.28–2.85) | 0 | ** | ** | ** |
Pancreatitis | 6 (0.8) | 0.80 (0.20–3.23) | 0 | ** | ** | ** |
Paralysis | 13 (1.7) | 1.89 (0.83–4.30) | 2 | 9 (1.2) | 2.31 (1.06–5.02) | 2 |
Peptic ulcer | 18 (2.3) | 0.95 (0.46–1.94) | 0 | 15 (1.9) | 1.25 (0.51–3.09) | 1 |
Psychoses | 23 (3) | 1.43 (0.75–2.72) | 1 | 8 (1.0) | 1.10 (0.27–4.46) | 1 |
Pulmonary circulation disorders | 7 (0.9) | 0.79 (0.29–2.20) | 0 | ** | ** | ** |
PVD | 6 (0.8) | 0.23 (0.03–1.67) | 0 | 6 (0.8) | 1.23 (0.30–5.02) | 1 |
Renal disease | 34 (4.4) | 2.37 (1.55–3.62) | 2 | 5 (0.6) | 8.56 (2.53–28.9) | 9 |
Rheumatoid disease | 7 (0.9) | 1.77 (0.65–4.84) | 2 | 6 (0.8) | 1.77 (0.65–4.84) | 2 |
Sleep disorders | 5 (0.6) | 1.91 (0.60–6.08) | 2 | ** | ** | ** |
Urinary tract disorders | 7 (0.9) | 2.19 (0.87–5.52) | 2 | ** | ** | ** |
Valvular diseases | 13 (1.7) | 1.48 (0.65–3.39) | 1 | 6 (0.8) | 1.46 (0.20–10.7) | 1 |
Weight loss | 17 (2.2) | 2.97 (1.71–5.16) | 3 | 7 (0.9) | 1.21 (0.30–4.94) | 1 |